Relapsed/Refractory Large B-cell Lymphoma
10 clinical trials · Condition
◉ Watch Relapsed/Refractory Large B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma (NCT04314843) | Kite, A Gilead Company | 2020-05-26 |
| Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma (NCT03939026) | Allogene Therapeutics | 2019-05-01 |
| Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma (NCT03704298) | Kite, A Gilead Company | 2018-11-20 |
Track Relapsed/Refractory Large B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.